These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Ovulation inhibitors and tumors]. Freundl G; Brossmann H Dtsch Med Wochenschr; 1985 Aug; 110(35):1346-50. PubMed ID: 3896722 [No Abstract] [Full Text] [Related]
4. [Current status of the tumor risk from oral contraception. The statement of the Standing Committee on Hormone Toxicology of the German Society for Endocrinology]. Hammerstein J; Bolt HM; Breckwoldt M; von Eickstedt KW; Elger W; Hoffmann B; Köbberling J; Knorr D; Nieschlag E; Nocke W Dtsch Med Wochenschr; 1987 May; 112(22):897-9. PubMed ID: 3034544 [No Abstract] [Full Text] [Related]
5. Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers. Prentice RL Prev Med; 1991 Jan; 20(1):38-46. PubMed ID: 1848935 [TBL] [Abstract][Full Text] [Related]
6. Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill? Olsson H Med Oncol Tumor Pharmacother; 1990; 7(1):61-4. PubMed ID: 2187124 [No Abstract] [Full Text] [Related]
8. [Does the "pill" promote the development of tumors?]. Lauritzen C Med Klin; 1980 Aug; 75(16):6-7. PubMed ID: 6251352 [No Abstract] [Full Text] [Related]
10. Neoplasia and hormonal contraception. Huggins GR Clin Obstet Gynecol; 1981 Sep; 24(3):903-25. PubMed ID: 7026111 [TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives: a possible association with liver tumors and endometrial carcinoma. Hanson FW Adv Plan Parent; 1977; 12(2):86-92. PubMed ID: 334603 [No Abstract] [Full Text] [Related]